4.14 million. 2. The cost of medical treatments when compared to income from medical treatments decreased 5.06% due to the cost of medical treatments from CMR went down 9.00% and the cost of medical
from the same period of last year due to loss on forward contract caused by foreign exchange volatility during the Covid-19 pandemic. 1.2 Cost of goods sold and expenses Consolidated financial statements
. The cost of medical treatments when compared to income from medical treatments decreased 5.06% due to the cost of medical treatments from CMR went down 9.00% and the cost of medical treatments in the
governance, appropriate risk management and effective cost management. At the same time, we have focused on collaboration and synergy with other companies within KASIKORNBANK FINANCIAL CONGLOMERATE, Muang Thai
Portugal) and higher cost of raw materials. Profit after tax and NCI of $819 million, up 33% YoY. TRIS Rating (an S&P partner) upgrade IVL to AA- from its earlier rating of A+. Indorama Ventures 2018 MD
during first half of 2017. However, the increasing in domestic sales push up the total revenue becoming minor decreasing. Cost of goods sold of Q3/17 is increased by 5.86% comparing with Q2/17 and 7.82
Operating results of the Company for the three-month period ended 31 March 2019 and 2018 are as follows: Revenue by segment Revenue Cost Gross Profit For three-month period ended 31 March For three-month
Details of the costs involving to the WTGs foundation improvement for Huay Bong 2&3 Wind Farm at September 30, 2017 are as shown in the table. Description Estimated total improvement cost (until year 2016
foundation improvement for Huay Bong 2&3 Wind Farm as at December 31, 2017 are as shown in the table. Description Estimated total improvement cost (as of year 2016) Estimate and cost for accounting recorded in
81.93 million of 1st quarter of year 2018. Sales and administrative expenses (Special entry) was Baht 18.59 million result from compensation for loss of production cost which increased comparing to the